Converge Bio is an Israeli biotech and ai company1 founded in 20241.
It has raised $25M across 1 funding round1; the most recent was a Series A round of $25M1, announced Jan 13, 20261.
Funding history
| Round | Announced | Amount | Lead investors |
|---|---|---|---|
| Series A | Jan 13, 2026 | $25M | Bessemer Venture Partners |
Investors
Which Israeli startups are similar to Converge Bio?
Sources
- 1CTech, Jan 13, 2026. “Converge Bio raises $25 million Series A to accelerate AI drug discovery”
How much funding has Converge Bio raised?
Converge Bio has raised $25M across 1 funding round.
What was Converge Bio’s latest funding round?
Converge Bio’s most recent round was a Series A round of $25M, announced Jan 13, 2026.
Who has invested in Converge Bio?
Investors in Converge Bio include Bessemer Venture Partners, TLV Partners, Vintage Investment Partners and Saras Capital.
When was Converge Bio founded?
Converge Bio was founded in 2024.